Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.34 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23768622 | 0.94 | AKR1C4 (0.34) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL18541214 | 0.92 | TSPO (0.36) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL25086334 | 0.91 | KDM4E (0.35) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL26499424 | 0.86 | PTGER4 (0.33) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL25487803 | 0.85 | KDM4E (0.39) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL26216515 | 0.85 | KDM4E (0.33) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL26380790 | 0.85 | NR4A2 (0.33) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL25527683 | 0.84 | TSPO (0.34) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E | |
| SCHEMBL25804029 | 0.83 | AKR1C4 (0.33) | AKR1C4AKR1C3AKR1C2AKR1C1PTGER4 | |
| SCHEMBL26437975 | 0.81 | PTGER4 (0.34) | AKR1C4AKR1C3AKR1C2AKR1C1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230130110-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-27 | — | — | US | disclosed |
| US-20210257554-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210257554-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SOD1, PIEZO1, L1CAM | AKR1C4 4634/4885AKR1C3 4777/4885AKR1C2 4539/4885 |
| US-20230130110-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SOD1, PIEZO1, L1CAM | AKR1C4 4634/4885AKR1C3 4777/4885AKR1C2 4539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.